Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model

We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated t...

Descripción completa

Detalles Bibliográficos
Autores Principales: Yandar, Nubia, Pastorin, Giorgia, Prato, Maurizio, Bianco, Alberto, Patarroyo, Manuel Elkin, Lozano, José Manuel
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2008
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23447
https://doi.org/10.1016/j.vaccine.2008.08.014
id ir-10336-23447
recordtype dspace
spelling ir-10336-234472022-05-02T12:37:21Z Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model Yandar, Nubia Pastorin, Giorgia Prato, Maurizio Bianco, Alberto Patarroyo, Manuel Elkin Lozano, José Manuel Apical membrane antigen 1 Carbon nanotube Drug carrier Polyclonal antibody Amino terminal sequence Animal experiment Animal model Article Bagg albino mouse Conjugation Controlled study Drug delivery system Drug structure Female Immune system Immunogenicity Malaria Mouse Nonhuman Parasitemia Plasmodium berghei Plasmodium vivax Priority journal Alleles Amino acid sequence Animals Cytokines Drug delivery systems Enzyme-linked immunosorbent assay Female Fluorescent antibody technique Hla-dr antigens Malaria Malaria vaccines Membrane proteins Mice Molecular sequence data Nanotubes Plasmodium berghei Plasmodium vivax Protozoan proteins Apical membrane antigen 1 (ama-1) Functionalized carbon nanotubes (f-cnt) Synthetic vaccine delivery system electron inbred balb c mhc class ii protozoan subunit western Antigens Blotting Genes Mice Microscopy Vaccines We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated to CNTs as well as being recognized by BALB/c polyclonal antibodies. Subsequent experiments lead us to assess the AMA-1 peptide alone, as well as the CNT-peptide conjugate regarding rodent malarial infection. Remarkably, the peptide effectively controlled and delayed Plasmodium berghei-challenged animals' parasitaemia. The peptide-CNT conjugate displayed similar immunological properties to the peptide alone by protecting or delaying malarial infection. The peptide presentation by f-CNT to the immune system thus constitutes a promising approach for synthetic malarial vaccine formulation since the immunogen peptide conformation is well preserved. © 2008 Elsevier Ltd. All rights reserved. 2008 2020-05-26T00:02:05Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 0264410X 13588745 https://repository.urosario.edu.co/handle/10336/23447 https://doi.org/10.1016/j.vaccine.2008.08.014 eng info:eu-repo/semantics/openAccess application/pdf instname:Universidad del Rosario
institution EdocUR - Universidad del Rosario
collection DSpace
language Inglés (English)
topic Apical membrane antigen 1
Carbon nanotube
Drug carrier
Polyclonal antibody
Amino terminal sequence
Animal experiment
Animal model
Article
Bagg albino mouse
Conjugation
Controlled study
Drug delivery system
Drug structure
Female
Immune system
Immunogenicity
Malaria
Mouse
Nonhuman
Parasitemia
Plasmodium berghei
Plasmodium vivax
Priority journal
Alleles
Amino acid sequence
Animals
Cytokines
Drug delivery systems
Enzyme-linked immunosorbent assay
Female
Fluorescent antibody technique
Hla-dr antigens
Malaria
Malaria vaccines
Membrane proteins
Mice
Molecular sequence data
Nanotubes
Plasmodium berghei
Plasmodium vivax
Protozoan proteins
Apical membrane antigen 1 (ama-1)
Functionalized carbon nanotubes (f-cnt)
Synthetic vaccine delivery system
electron
inbred balb c
mhc class ii
protozoan
subunit
western
Antigens
Blotting
Genes
Mice
Microscopy
Vaccines
spellingShingle Apical membrane antigen 1
Carbon nanotube
Drug carrier
Polyclonal antibody
Amino terminal sequence
Animal experiment
Animal model
Article
Bagg albino mouse
Conjugation
Controlled study
Drug delivery system
Drug structure
Female
Immune system
Immunogenicity
Malaria
Mouse
Nonhuman
Parasitemia
Plasmodium berghei
Plasmodium vivax
Priority journal
Alleles
Amino acid sequence
Animals
Cytokines
Drug delivery systems
Enzyme-linked immunosorbent assay
Female
Fluorescent antibody technique
Hla-dr antigens
Malaria
Malaria vaccines
Membrane proteins
Mice
Molecular sequence data
Nanotubes
Plasmodium berghei
Plasmodium vivax
Protozoan proteins
Apical membrane antigen 1 (ama-1)
Functionalized carbon nanotubes (f-cnt)
Synthetic vaccine delivery system
electron
inbred balb c
mhc class ii
protozoan
subunit
western
Antigens
Blotting
Genes
Mice
Microscopy
Vaccines
Yandar, Nubia
Pastorin, Giorgia
Prato, Maurizio
Bianco, Alberto
Patarroyo, Manuel Elkin
Lozano, José Manuel
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
description We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated to CNTs as well as being recognized by BALB/c polyclonal antibodies. Subsequent experiments lead us to assess the AMA-1 peptide alone, as well as the CNT-peptide conjugate regarding rodent malarial infection. Remarkably, the peptide effectively controlled and delayed Plasmodium berghei-challenged animals' parasitaemia. The peptide-CNT conjugate displayed similar immunological properties to the peptide alone by protecting or delaying malarial infection. The peptide presentation by f-CNT to the immune system thus constitutes a promising approach for synthetic malarial vaccine formulation since the immunogen peptide conformation is well preserved. © 2008 Elsevier Ltd. All rights reserved.
format Artículo (Article)
author Yandar, Nubia
Pastorin, Giorgia
Prato, Maurizio
Bianco, Alberto
Patarroyo, Manuel Elkin
Lozano, José Manuel
author_facet Yandar, Nubia
Pastorin, Giorgia
Prato, Maurizio
Bianco, Alberto
Patarroyo, Manuel Elkin
Lozano, José Manuel
author_sort Yandar, Nubia
title Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_short Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_full Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_fullStr Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_full_unstemmed Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
title_sort immunological profile of a plasmodium vivax ama-1 n-terminus peptide-carbon nanotube conjugate in an infected plasmodium berghei mouse model
publishDate 2008
url https://repository.urosario.edu.co/handle/10336/23447
https://doi.org/10.1016/j.vaccine.2008.08.014
_version_ 1740173068421038080
score 12,131701